MNPR — Monopar Therapeutics Share News
0.000.00%
Last trade - 00:00- $487.17m
- $352.87m
Brief: Monopar Therapeutics Files Prospectus Relates To Resale From Time To Time Of Up To 705,015 Shares Of Common Stock By Selling Stockholder
U.S. STOCKS ON THE MOVE-Williams-Sonoma, Inspire Medical
U.S. STOCKS ON THE MOVE-Williams-Sonoma, Inspire Medical, Lemonade Inc
U.S. STOCKS ON THE MOVE-Comcast, Wix.com, Flex
JonesTrading raises PT on Monopar Therapeutics after AstraZeneca agreement
U.S. RESEARCH ROUNDUP- Apellis Pharmaceuticals, Energizer Holdings, Walmart
Monopar Therapeutics Inc reports results for the quarter - Earnings Summary
Brief: RA Capital Management Reports 9.7% Passive Stake In Monopar Therapeutics
Brief: Monopar Therapeutics Announces Pricing Of $19.2 Million Public Offering Of Common Stock
Brief: Monopar Therapeutics Announces Proposed Public Offering
Microcap Monopar Therapeutics tumbles on planned stock offering
Brief: Astrazeneca Reports 9.9% Passive Stake In Monopar Therapeutics As Of Oct 23 - SEC Filing
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
U.S. STOCKS ON THE MOVE-Teck Resources, Nasdaq, T-Mobile
Monopar rises on drug licensing deal with AstraZeneca
U.S. STOCKS ON THE MOVE-United Parcel Service, Boeing
U.S. STOCKS ON THE MOVE-Tesla, Dow, Harley-Davidson
Monopar rises on drug licensing deal with AstraZeneca
Brief: Monopar Initiates Clinical Trial Of Novel uPAR-Targeted Radiopharmaceutical Therapy In Advanced Cancers